Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, and, MI, Detroit, MI, USA; Perinatal Research Initiative in Maternal, Perinatal and Child Health, Wayne State University School of Medicine, Detroit, MI, USA; Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine, Detroit, MI, USA.
Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, and, MI, Detroit, MI, USA; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA; Detroit Medical Center, Detroit, MI, USA.
J Reprod Immunol. 2022 Feb;149:103460. doi: 10.1016/j.jri.2021.103460. Epub 2021 Dec 8.
Microbial invasion of the amniotic cavity (MIAC) leading to infection is strongly associated with adverse pregnancy and neonatal outcomes. Limitations of current diagnostic assays to detect MIAC rapidly and accurately have hindered the ability of obstetricians to identify and treat intra-amniotic infections. We developed, optimized, and validated two multiplex quantitative polymerase chain reaction (qPCR) assays for the simultaneous detection and quantification of microbial taxa commonly associated with MIAC. The first assay allows for the quantification of general bacterial and fungal loads in amniotic fluid and includes a human reference gene to allow for assessing the integrity of clinical samples and the DNA extraction process. The second assay allows for the detection and quantification of four specific bacterial taxa commonly associated with MIAC: Ureaplasma spp., Mycoplasma hominis, Streptococcus agalactiae, and Fusobacterium nucleatum. The qPCR assays were validated by using both microbial isolates and clinical amniotic fluid samples. The assays were further validated by comparing qPCR amplification results to those from the microbial culture and bacterial 16S rRNA gene sequencing of amniotic fluid. Both assays demonstrated high reproducibility and are sensitive and specific to their intended targets. Therefore, these assays represent promising molecular diagnostic tools for the detection of MIAC. Most importantly, these assays may allow for administration of timely and targeted antibiotic interventions to reduce adverse perinatal outcomes attributed to intra-amniotic infections.
微生物侵袭羊膜腔(MIAC)导致感染与不良妊娠和新生儿结局密切相关。目前用于快速准确检测 MIAC 的诊断检测方法存在局限性,这阻碍了产科医生识别和治疗羊膜内感染的能力。我们开发、优化和验证了两种用于同时检测和定量与 MIAC 相关的常见微生物类群的多重定量聚合酶链反应(qPCR)检测方法。第一个检测方法可以定量羊水总细菌和真菌负荷,并包含一个人类参考基因,以评估临床样本和 DNA 提取过程的完整性。第二个检测方法可以检测和定量与 MIAC 相关的四种特定细菌类群:解脲支原体、人型支原体、无乳链球菌和核梭杆菌。使用微生物分离株和临床羊水样本对 qPCR 检测方法进行了验证。通过比较 qPCR 扩增结果与微生物培养和羊水细菌 16S rRNA 基因测序的结果,进一步验证了这些检测方法。两种检测方法均表现出高度的重现性,对其预期目标具有敏感性和特异性。因此,这些检测方法代表了 MIAC 检测的有前途的分子诊断工具。最重要的是,这些检测方法可能允许及时进行靶向抗生素干预,以减少归因于羊膜内感染的不良围产期结局。